louisiana semaglutide class action gastrointestinal obstruction Ozempic Lawsuit for Gastroparesis Hims & Hers class action

Read the Bloomberg article here...

Combining testosterone replacement therapy with GLP-1 receptor agonists is increasingly common among men pursuing dual metabolic and hormonal optimization

Pushing the Boundaries of GLP-1 Innovation Hanmi to Present Six Obesity Drug Studies at ADA 2025Hanmi Pharmaceutical to Unveil Six Research Updates on HM15275 and HM17321 at ADA 2025Phase 1 Results of Next-Generation Triple Agonist HM15275 to Be Unveiled for the First Time

If you've been taking GLP-1's or a semaglutide like Ozempic, Wegovy, Zepbound, and Mounjaro but are thinking about stopping, it's important to learn how to N...